Sustained-release compositions for parenteral administration
US6552002B2 · kind B2 · utility
6Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2001 |
| Grant date | Apr 22, 2003 |
| Priority date | — |
| Expiry date | Mar 15, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P33/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Sustained-release compositions comprising a macrolide compound, a surfactant, a co-solvent, and a solvent. The sustained-release compositions of this invention may be parenterally administered to animals, and are useful for preventing or treating helminth, acarid or arthropod endo- or ectoparasitic infection or infestation in warm-blooded animals for prolonged periods of time.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.